August 10, 2015 article Open access Pembrolizumab Journal for ImmunoTherapy of Cancer DOI: 10.1186/s40425-015-0078-9 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 3 stored of 225 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Phase I/Ib Clinical Trial of Sabatolimab, an Anti–TIM-3 Antibody, Alone and in Combination with Spartalizumab, an Anti–PD-1 Antibody, in Advanced Solid Tumors 2021 Clinical Cancer Research article Medicine Cancer Immunotherapy and Biomarkers Open access cited by 7 patents 359 citations PD-1 Blockade in Anaplastic Thyroid Carcinoma 2020 Journal of Clinical Oncology article Medicine Thyroid Cancer Diagnosis and Treatment Open access 351 citations A first-in-human phase 1 dose escalation study of spartalizumab (PDR001), an anti–PD-1 antibody, in patients with advanced solid tumors 2020 Journal for ImmunoTherapy of Cancer article Medicine Cancer Immunotherapy and Biomarkers Open access cited by 1 patent 86 citations 3 results References 0